Jeremy Gottlieb
Overview
Explore the profile of Jeremy Gottlieb including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
156
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Dumas M, Laly P, Gottlieb J, Vercellino L, Paycha F, Bagot M, et al.
Melanoma Res
. 2018 Aug;
28(6):641-644.
PMID: 30124538
Targeted therapies have markedly improved the survival of patients with melanoma. We report the case of two patients with advanced melanoma controlled by long-term MEK inhibitor or combination of BRAF...
12.
Lhote R, Lambert J, Lejeune J, Gottlieb J, Badaoui A, Battistella M, et al.
Acta Derm Venereol
. 2018 Apr;
98(7):671-676.
PMID: 29648676
Cutaneous squamous cell carcinoma (cSSC) is one of the most common skin cancers and can lead to patient death. Early detection of node metastasis is a major goal for dermatologists...
13.
Gauci M, Laly P, Leonard-Louis S, Behin A, Gottlieb J, Madelaine-Chambrin I, et al.
Melanoma Res
. 2017 Jul;
27(5):511-515.
PMID: 28692456
Therapeutic advances derived from targeted therapy and immune checkpoint inhibitors can improve melanoma prognosis. Since 2015, cobimetinib has been approved in combination with vemurafenib in the first-line treatment for BRAF-mutated...
14.
Gauci M, Laly P, Vidal-Trecan T, Baroudjian B, Gottlieb J, Madjlessi-Ezra N, et al.
Cancer Immunol Immunother
. 2017 Jun;
66(11):1399-1410.
PMID: 28634815
Anti-PD-1 antibody treatment is approved in advanced melanoma and provides median overall survival over 24 months. The main treatment-related side effects are immune-related adverse events, which include rash, pruritus, vitiligo,...
15.
Haber R, Gottlieb J, Zagdanski A, Battistella M, Bachelez H
JAAD Case Rep
. 2017 Apr;
3(3):182-184.
PMID: 28443304
No abstract available.
16.
Aouidad I, Schneider P, Zmuda M, Gottlieb J, Viguier M
JAMA Dermatol
. 2017 Jan;
153(3):355-356.
PMID: 28055067
No abstract available.
17.
Gauci M, Jachiet M, Gottlieb J, Madeleine-Chambrin I, Rybojad M, Bagot M, et al.
JAAD Case Rep
. 2016 Dec;
2(6):462-464.
PMID: 27981219
No abstract available.